Similarly, experimental AT1 blockage has shown growth inhibition in other neoplasms such as melanoma (Egami et al, 2003), lung carcinoma (Fujita et al, 2005), prostate adenocarcinoma (Uemura et al, 2005), renal cancer (Miyajima et al, 2002), and pancreatic cancer (Fujimoto et al, 2001). This evidence concerns the gene AGTR1 and lung carcinoma.